DK0507934T3 - Polypeptider der er involveret i ekspression af resistens over for glycopeptidantibiotika - Google Patents

Polypeptider der er involveret i ekspression af resistens over for glycopeptidantibiotika

Info

Publication number
DK0507934T3
DK0507934T3 DK91920753T DK91920753T DK0507934T3 DK 0507934 T3 DK0507934 T3 DK 0507934T3 DK 91920753 T DK91920753 T DK 91920753T DK 91920753 T DK91920753 T DK 91920753T DK 0507934 T3 DK0507934 T3 DK 0507934T3
Authority
DK
Denmark
Prior art keywords
expression
resistance
glycopeptide antibiotics
polypeptides involved
polypeptides
Prior art date
Application number
DK91920753T
Other languages
Danish (da)
English (en)
Inventor
Sylvie Dukta-Malen
Michel Arthur
Catherine Molinas
Patrice Courvalin
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0507934T3 publication Critical patent/DK0507934T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91920753T 1990-10-31 1991-10-29 Polypeptider der er involveret i ekspression af resistens over for glycopeptidantibiotika DK0507934T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9013579A FR2668489A1 (fr) 1990-10-31 1990-10-31 Sequences nucleotidiques et polypeptidiques impliquees dans l'expression de la resistance aux glycopeptides. utilisation pour le diagnostic.
PCT/FR1991/000855 WO1992007942A1 (fr) 1990-10-31 1991-10-29 Polypeptides impliques dans l'expression de la resistance aux antibiotiques glycopeptidiques

Publications (1)

Publication Number Publication Date
DK0507934T3 true DK0507934T3 (da) 2007-05-14

Family

ID=9401774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920753T DK0507934T3 (da) 1990-10-31 1991-10-29 Polypeptider der er involveret i ekspression af resistens over for glycopeptidantibiotika

Country Status (9)

Country Link
US (1) US6013508A (zh)
EP (2) EP1785487A3 (zh)
JP (3) JP3404533B2 (zh)
CA (3) CA2637710C (zh)
DE (1) DE69133555T2 (zh)
DK (1) DK0507934T3 (zh)
ES (1) ES2280079T3 (zh)
FR (1) FR2668489A1 (zh)
WO (1) WO1992007942A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2699539B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquence de nucléotides codant pour cette protéine.
FR2699537B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquences de nucléotides codant pour cette protéine.
US5770690A (en) * 1995-06-27 1998-06-23 Neurex Corporation Bax omega protein and methods
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US6270992B1 (en) * 1997-07-29 2001-08-07 Smithkline Beecham Corporation Histidine kinase of Staphylococcus aureus
EP1210365A2 (en) * 1999-08-17 2002-06-05 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus
WO2007014045A2 (en) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
EP2473630B1 (en) * 2009-09-04 2017-11-08 QIAGEN GmbH Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
FR2994270B1 (fr) * 2012-08-01 2020-01-03 Biomerieux Procede de detection d'au moins un mecanisme de resistance aux glycopeptides par spectrometrie de masse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
FR2699537B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquences de nucléotides codant pour cette protéine.

Also Published As

Publication number Publication date
JPH05503222A (ja) 1993-06-03
DE69133555T2 (de) 2007-10-25
CA2072350C (fr) 2004-11-30
WO1992007942A1 (fr) 1992-05-14
CA2637710C (fr) 2010-12-14
JP2002320494A (ja) 2002-11-05
ES2280079T3 (es) 2007-09-01
FR2668489B1 (zh) 1995-03-31
JP3404533B2 (ja) 2003-05-12
CA2475116A1 (fr) 1992-05-14
DE69133555D1 (de) 2007-02-22
CA2072350A1 (fr) 1992-05-01
EP0507934B1 (fr) 2007-01-10
CA2637710A1 (fr) 1992-05-14
EP1785487A3 (fr) 2012-01-11
CA2475116C (fr) 2008-12-02
US6013508A (en) 2000-01-11
FR2668489A1 (fr) 1992-04-30
JP4128905B2 (ja) 2008-07-30
EP0507934A1 (fr) 1992-10-14
JP2004024251A (ja) 2004-01-29
EP1785487A2 (fr) 2007-05-16

Similar Documents

Publication Publication Date Title
BR9100262A (pt) Composicao de moldagem
BG94328A (bg) Полипептиди
BR8901080A (pt) Composicao de revestimento aquosa auto-reticulavel
FI891990A (fi) Jäänmuodostusta estäviä päällystyskoostumuksia
BR9106995A (pt) Inibicao de interacoes proteina-carboidrato com adesao celular
DE69223033T2 (de) Fluorgummi-beschichtungszusammensetzung
DE69118071D1 (de) Polypropylenzusammensetzung
DE69128369D1 (de) Beschichtungszusammensetzung
DE69131159T2 (de) Vernetzbare Elastomerzusammensetzung
DE69119298D1 (de) Zusammensetzung mit guten Gleiteigenschaften
DK0507934T3 (da) Polypeptider der er involveret i ekspression af resistens over for glycopeptidantibiotika
DE69119829D1 (de) Pulverbeschichtungszusammensetzung
DE69131284T2 (de) Sekretionskörper enthaltende Zusammensetzung
DK273089D0 (da) Anvendelse af peptidderivater
DE69121634D1 (de) Silikonkautschukzusammensetzung
DE69131455D1 (de) Klebstoffzusammensetzung
DE69122548D1 (de) Einkomponenten-Dichtungszusammensetzung
UA26064A1 (uk) Фармацевтичhа композиція
DE69126633D1 (de) Leitfähige Harzzusammensetzung
DK199689A (da) Expression af humant interleukin-2 i methylotrophe gaerarter
DK196689A (da) Ekspression af praes2-proteinet for hepatitis b i methylotrophe gaerarter
NO923660D0 (no) Beleggsammensetning
DE69122478D1 (de) Feste zusammensetzung
BR9103734A (pt) Composicoes
DE69130639D1 (de) Einzel-flüssigkeit zusammensetzung